BeStock  
Stocks › Biotechnology › SLDB

Solid Biosciences SLDB

US equityMarket cap rank #3471Biotechnology
$6.85 −$0.07 (-1.01%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $6.85 0.00%
Open$6.76
Prev close$6.92
Day range$6.69 – $6.98
Volume744.7K
Market cap$734.49M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$57.38M-37.6% YoY
Net profit-$54.80M-38.8% YoY
Diluted EPS-$0.38+9.5% YoY
Free cash flow-$52.74M-39.6% YoY
Operating cash flow-$52.59M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-32.7MSep '24$-42.6MDec '24$-39.3MMar '25$-39.5MJun '25$-45.8MSep '25$-49.8MDec '25$-56.7MMar '26$-54.8MJun '26

Diluted EPS by quarter

-0.79Sep '24-1.02Dec '24-0.59Mar '25-0.42Jun '25-0.48Sep '25-0.53Dec '25-0.52Mar '26-0.38Jun '26

Free cash flow by quarter

$-23.7MSep '24$-29.8MDec '24$-32.0MMar '25$-37.8MJun '25$-33.6MSep '25$-54.1MDec '25$-47.4MMar '26$-52.7MJun '26

Annual revenue

$0.0FY20$13.6MFY21$8.1MFY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-65.5%
Return on assets-56.8%
Return on invested capital-64.3%
Current ratio13.82
Liabilities / assets11.1%
Cash & investments$377.68M
Total debt$17.92M
Net cash (debt)$359.76M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $0.00 $0.00 – – $0.00
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $57.38M $57.31M $179.21M $49.40M $48.06M
Selling and Admin Expenses $13.12M $11.17M $38.88M $11.27M $9.20M
-General & Admin Expense $13.12M $11.17M $38.88M $11.27M $9.20M
Research & Development $44.27M $46.14M $140.33M $38.14M $38.86M
Operating Profit -$57.38M -$57.31M -$179.21M -$49.40M -$48.06M
Net Non-Operating Interest Income (Expense) $3.22M $2.06M $10.11M $2.05M $2.92M
Non-Operating Interest Income $3.22M $2.06M $10.11M $2.05M $2.92M
Non-Operating Interest Expense $0.00 $0.00 – – –
Other Income (Expense) -$636,000.00 -$1.49M -$5.23M -$2.43M -$640,000.00
Gain on Sale of Security -$850,000.00 -$1.65M -$6.05M -$2.65M -$850,000.00
Other Non-Operating Income (Expenses) $214,000.00 $157,000.00 $824,000.00 $219,000.00 $210,000.00
Pretax Profit -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Net Profit -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Profit from Continuing Operations -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Net Income to Parent Company -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Net Income to Common Stockholders -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Basic EPS -$0.38 -$0.52 -$1.99 -$0.53 -$0.48
Diluted EPS -$0.38 -$0.52 -$1.99 -$0.53 -$0.48

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $420.58M $422.89M $232.54M $232.54M $273.91M
Total Current Assets $395.11M $396.79M $205.46M $205.46M $244.85M
Cash and Cash Equivalents & Short-Term Investments $377.68M $380.68M $187.85M $187.85M $236.14M
-Cash and Cash Equivalents $159.39M $297.10M $59.90M $59.90M $61.36M
-Short Term Investments $218.28M $83.58M $127.95M $127.95M $174.78M
Prepaid Assets $13.86M $12.49M $13.97M $13.97M $5.60M
Restricted Cash $638,000.00 $638,000.00 $1.22M $1.22M –
Other Current Assets $2.93M $2.98M $2.42M $2.42M $3.11M
Total Non-Current Assets $25.47M $26.11M $27.08M $27.08M $29.06M
Net PPE $24.63M $25.21M $26.09M $26.09M $26.89M
-Gross PPE $24.63M $25.21M $40.28M $40.28M $26.89M
Other Non-Current Assets $846,000.00 $891,000.00 $991,000.00 $991,000.00 $2.17M
Total Liabilities $46.51M $48.76M $52.53M $52.53M $55.97M
Total Current Liabilities $28.58M $30.28M $33.47M $33.47M $36.34M
Payables $4.36M $5.56M $3.22M $3.22M $8.43M
-Accounts Payable $4.36M $5.56M $3.22M $3.22M $8.43M
Current Accrued Expenses $11.57M $14.80M $10.13M $10.13M $11.89M
Short-Term Debt and Capital Lease Obligation $2.23M $2.19M $2.10M $2.10M $2.31M
-Current Capital Lease Obligation $2.23M $2.19M $2.10M $2.10M $2.31M
Other Current Liabilities $4.20M $3.35M $9.20M $9.20M $6.55M
Total Non-Current Liabilities $17.92M $18.48M $19.06M $19.06M $19.62M
Long Term Debt and Capital Lease Obligation $17.92M $18.48M $19.06M $19.06M $19.62M
-Long Term Capital Lease Obligation $17.92M $18.48M $19.06M $19.06M $19.62M
Total Equity $374.08M $374.13M $180.01M $180.01M $217.95M
Stockholders' Equity $374.08M $374.13M $180.01M $180.01M $217.95M
Capital Stock $105,000.00 $98,000.00 $79,000.00 $79,000.00 $78,000.00
-Common Stock $105,000.00 $98,000.00 $79,000.00 $79,000.00 $78,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.44B $1.39B $1.14B $1.14B $1.13B
Retained Earnings -$1.07B -$1.01B -$957.78M -$957.78M -$907.99M
Gains/Losses Not Affecting Retained Earnings -$113,000.00 -$13,000.00 $52,000.00 $52,000.00 $48,000.00
-Accumulated Depreciation – – -$14.19M -$14.19M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$52.59M -$47.23M -$156.29M -$53.56M -$33.47M
Net cash flow from continuing operations -$52.59M -$47.23M -$156.29M -$53.56M -$33.47M
Net Income from Continuing Operations -$54.80M -$56.74M -$174.33M -$49.79M -$45.78M
Gain/Loss from Continuing Operations $850,000.00 $1.65M $6.05M $2.65M $850,000.00
Depreciation & Depletion & Amortization $391,000.00 $395,000.00 $1.64M $467,000.00 $376,000.00
Other Non-Cash Items $659,000.00 $623,000.00 $2.13M $611,000.00 $304,000.00
Change in Working Capital -$3.94M $2.31M -$6.82M -$13.25M $7.17M
-Change in Prepaid Assets -$1.28M $954,000.00 -$7.99M -$7.65M $1.72M
-Change in Payables and Accrued Expense -$2.15M $1.85M $2.96M -$5.11M $5.90M
-Change in Other Current Liabilities -$510,000.00 -$496,000.00 -$1.79M -$495,000.00 -$443,000.00
Net cash flow from investing -$133.59M $44.76M -$58.45M $47.01M -$45.27M
Net Cash Flow from Continuing Investing Activities -$133.59M $44.76M -$58.45M $47.01M -$45.27M
Net PPE Purchase and Sale -$150,000.00 -$165,000.00 -$1.07M -$480,000.00 -$85,000.00
Net Investment Purchase and Sale -$133.44M $44.92M -$57.39M $47.58M -$45.19M
Financing Cash Flow $48.47M $239.03M $194.45M $5.14M $1.18M
Net Cash Flow from Continuing Financing Activities $48.47M $239.03M $194.45M $5.14M $1.18M
Net Issuance Payments Of Debt $0.00 $0.00 -$723,000.00 -$203,000.00 -$243,000.00
Net Common Stock Issuance $48.12M $239.01M $194.74M $5.12M $1.42M
Proceeds from Stock Option Exercised $351,000.00 $18,000.00 $431,000.00 $229,000.00 $0.00
Ending Cash Balance $160.74M $298.45M $61.89M $61.89M $63.29M
Net Change in Cash -$137.71M $236.56M -$20.30M -$1.40M -$77.57M
Beginning Cash Balance $298.45M $61.89M $82.19M $63.29M $140.86M
Free Cash Flow -$52.74M -$47.40M -$157.44M -$54.12M -$33.56M
Net Other Investing Changes – – – – $0.00

Discussion

No comments yet — be the first to weigh in on SLDB.

Leave a comment

Scroll to Top